loader
slider6

Full Service Biometricson major platforms
including kTrials

LEARN MORE
slider1

Cliantha Research acquiresInflamax Research

LEARN MORE
slider1

Successfully conductedmore than 5000 studies globally

LEARN MORE
slider2

60 years of Dermatology experience

LEARN MORE
slider3

Leading Biosimilars experience

LEARN MORE
slider4

More than Two Million Samples analyzed LC/MS/MS & ELISA using methods

LEARN MORE
slider5

50 Phase I-IV Oncology studiesconducted in past
5 years using methods

LEARN MORE

About Cliantha

Welcome to Cliantha Research, a global Contract Research Organization (CRO) providing integrated clinical offerings in Early Phase (Phase I/IIa), Late Phase (Phase II-IV), Bioequivalence (BA/BE), Clinical Endpoint Trials, Bioanalytical, Biosimilars, Dermatology, Respiratory, Allergy, Biometrics, and Personal Healthcare services. Our services have science at its foundation that is developed through regular and systematic training of the Cliantha Team.

Cliantha offers Biosimilar, Biotech, Cosmetic, Generic, Personal Healthcare and Pharmaceutical companies a comprehensive range of clinical research and support services. You will notice we use our legacy brand names: Cliantha Research, Hill Top Research, Inflamax Research and Karmic Lifesciences, however, we operate as one company – Cliantha. We have added and enhanced the capabilities during the past 6 years in each of the companies to provide our sponsors with a single, global research network.

Regulatory Inspections

Last Inspection in Nov 2015
Inspected facility in Nov 2006
Inspected facility in Jan 2009
Last inspection in March 2017
Last inspection in April 2017
Last inspection in March 2013
Inspected facility in July 2013
Last inspected by Ministry of Health of Turkey in April 2013
Last inspection in April 2011

News & Events

21 Apr
2017

Cliantha Research acquires Inflamax Research

Cliantha Research is proud to announce the acquisition of Inflamax Research. Inflamax has locations in Toronto, ON, Neptune, NJ and Newark, NJ...

Learn More
20-23 March
2017

Cliantha at DCAT 2017

Cliantha will be attending DCAT once again. Our senior leaders Naveen Sharma, John Capicchioni and Rahul Nijhawan will be in attendance. They are looking forward to meeting with you...

Learn More
1 March
2017

Hill Top Research has successfully completed FDA inspection

USFDA inspection of Hill Top Research Inc. was conducted at our St. Petersburg, Florida site from Feb 22, 2017 to Mar 01, 2017...

Learn More
21 Feb
2017

Lecture & Panel Discussion at APA-India 2017

Dr. Shaifali Gupta, Laboratory Director, spoke on Biosimilars Bioanalysis: Challenges and Solutions at APA- India 2017 on 21 February’17 at Ahmedabad, India...

Learn More
20 Feb
2017

Poster presentation at APA-India 2017

Mr. Soumen Chakraborty presented a poster on “Bioanalytical Challenges in developing and validating a biomarker assay...

Learn More

Case Studies

Biosimilars Case Studies

Learn More

Nitroglycerine Study

Learn More

Potassium Chloride KCL study

Learn More